871024-38-3

Basic information

• Product Name: 4-Chloro-5-Methyl-5H-pyrrolo[3,2-d]pyriMidine
• Synonyms: 4-Chloro-5-Methyl-5H-pyrrolo[3,2-d]pyriMidine;4-Chloro-5-Methyl-5H-pyrr...
• CAS NO: 871024-38-3
• Molecular Formula: C₇H₆ClN₃
• Molecular Weight: 167.59564
• Mol File: 871024-38-3.mol
• Article Data: 7

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-Chloro-5-Methyl-5H-pyrrolo[3,2-d]pyriMidine(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Chloro-5-Methyl-5H-pyrrolo[3,2-d]pyriMidine(871024-38-3)
• EPA Substance Registry System: 4-Chloro-5-Methyl-5H-pyrrolo[3,2-d]pyriMidine(871024-38-3)

Safety Data

• RIDADR: UN2811
• Hazardous Substances Data: 871024-38-3(Hazardous Substances Data)

Usage

General Description

4-Chloro-5-Methyl-5H-pyrrolo[3,2-d]pyriMidine is a chemical compound with the molecular formula C7H6ClN3. It is a heterocyclic compound containing a five-membered pyrrole ring fused to a six-membered pyrimidine ring. 4-Chloro-5-Methyl-5H-pyrrolo[3,2-d]pyriMidine is used in the pharmaceutical industry as an intermediate in the synthesis of various pharmaceuticals, including antiviral and anticancer agents. Its unique structure and properties make it a valuable building block for the development of new drugs and therapeutic agents. Additionally, it is also utilized in chemical research and as a reference standard in analytical chemistry.

Upstream product

• 84905-80-6 4-Chloro-5H-pyrrolo[3,2-d]pyrimidine 
• 74-88-4 methyl iodide 
• 66-27-3 Methyl methanesulfonate 

Downstream Products

• 919278-19-6 4-(3-fluoro-4-nitrophenoxy)-5-methyl-5H-pyrrolo[3,2-d]pyrimidine 
• 919278-15-2 3-chloro-4-[(5-methyl-5H-pyrrolo[3,2-d]pyrimidin-4-yl)-oxy]aniline 
• 919278-71-0 3-[(5-methyl-5H-pyrrolo[3,2-d]pyrimidin-4-yl)oxy]benzoic acid 
• 1255948-53-8 4-[(5-methyl-5H-pyrrolo[3,2-d]pyrimidin-4-yl)sulfanyl]-aniline 
• 1346176-17-7 N-{3-chloro-4-[3-(trifluoromethyl)phenoxy]phenyl}-5-methyl-5H-pyrrolo[3,2-d]pyrimidin-4-amine hydrochloride 
• 1346176-16-6 N-[3-chloro-4-(3-chlorophenoxy)phenyl]-5-methyl-5H-pyrrolo[3,2-d]pyrimidin-4-amine hydrochloride 
• 1346176-18-8 N-{3-chloro-4-[3-(trifluoromethoxy)phenoxy]phenyl}-5-methyl-5H-pyrrolo[3,2-d]pyrimidin-4-amine hydrochloride 
• 919278-51-6 4-chloro-5-methyl-5H-pyrrolo[3,2-d]pyrimidine-6-carbonitrile 
• 940305-25-9 methyl 3-{2-chloro-4-[(5-methyl-5H-pyrrolo[3,2-d]pyrimidin-4-yl)amino]phenoxy}benzoate 
• 875339-19-8 4-(2-fluoro-4-nitrophenoxy)-5-methyl-5H-pyrrolo[3,2-d]pyrimidine 
• 919278-72-1 5-methyl-5H-pyrrolo[3,2-d]pyrimidin-4-ol 
• 919278-69-6 3-{[(5-methyl-5H-pyrrolo[3,2-d]pyrimidin-4-yl)oxy]methyl}aniline 
• 919278-29-8 2-methoxy-4-[(5-methyl-5H-pyrrolo[3,2-d]pyrimidin-4-yl)-oxy]aniline 
• 919278-09-4 2-chloro-4-[(5-methyl-5H-pyrrolo[3,2-d]pyrimidin-4-yl)-oxy]aniline 

Relevant articles and documents

PYRROPYRIMIDINE COMPOUNDS AS MNKS INHIBITORS

The present invention relates to compounds of formulae I, or pharmaceutically acceptable salts or esters thereof, wherein: R1 is selected from H and CO-NR8R9, wherein R8 and R9 are each independently

Synthesis of non-purine analogs of 6-aryl-9-benzylpurines, and their antimycobacterial activities. Compounds modified in the imidazole ring

Purine analogs modified in the five-membered ring have been synthesized and examined for antibacterial activity against Mycobacterium tuberculosis H 37Rv in vitro employing the microplate alamar blue assay (MABA). The 9-deaza analogs were only

FUSED HETEROCYCLIC COMPOUND

The present invention provides a fused heterocyclic compound having a tyrosine kinase inhibitory action, which is represented by the formula: wherein R1 is a hydrogen atom, a halogen atom, or an optionally substituted group bonded via a carbon atom, a nitrogen atom or an oxygen atom; R2 is a hydrogen atom, or an optionally substituted group bonded via a carbon atom or a sulfur atom, or R1 and R2, or R2 and R3 are optionally bonded to each other to form an optionally substituted ring structure; R3 is a hydrogen atom or an optionally substituted aliphatic hydrocarbon group, or R3 is optionally bonded to the carbon atom on ring A to form an optionally substituted ring structure; ring A is an optionally substituted benzene ring; and ring B is (i) an optionally substituted fused ring, or (ii) a pyridine ring having optionally substituted carbamoyl (the pyridine ring is optionally further substituted).